Home
overview

Understanding immunogenicity is a key challenge in the development of therapeutics with many biologics inducing undesirable immune responses directed towards the therapeutic resulting in reduced efficacy, anaphylaxis and occasionally life threatening autoimmunity. This conference explores the latest updates on the prediction and reduction of immunogenicity, clinical results and interpetations and optimising bioassays.

Led by selected case studies from leading drug developement teams, bioanalytical experts, and academics we aim to provide the insights and sharing necessary to deliver safe, efficacious large molecule drugs to improve the lives of patients.

  • Gain an understanding of immunogenicity and challenges in biologics development
  • Explore tolerance induction techniques in detail
  • Discover the latest in pre-clinical model
  • Learn more about neutralising antibody assay best practice
  • Receive updates on the ABIRISK project
   

AbbVie Ltd; Ablynx NV; Alcyomics ltd; AlgoNomics; Antitope Ltd; Apitope Technology Ltd; BMS; CPR Services ; EpiVax Inc; GENALYTE, INC; GSK; Intertek (ITS Testing); Kyowa Hakko Kirin UK Ltd; Lonza Biologics; Lonza Biologics Plc; Medimmune LLC; Medimmune ltd; MRC Human Nutrition Research; National Cancer Institute N I H; Pfizer; Protalix Ltd; Roche Diagnostics ; SciCross AB; Selecta Biosciences; Swedish Orphan Biovitrum ; TNO Triskelion ; UCB-Celltech; Uniformed Services University of Health Sciences; University Of Geneva; University of Salsburg; University of Vigo;

Conference programme

8:30 Registration & Coffee

9:00 Chair's Opening Remarks

Guilhem Richard

Guilhem Richard, Computational Immunologist, EpiVax Inc

9:10 How to switch off unwanted immune responses

David Wraith

David Wraith, Chief Scientific Officer and Founder, Apitope International NV

• Immunogenicity is unavoidable e.g. enzyme replacement therapy
• Immunological tolerance mechanisms control immune responses to self and foreign antigens
• The mechanisms of tolerance induction are now being revealed: here we will discuss novel insights into tolerance induction with peptide antigens
• Examples will be given from the fields of allergy, autoimmune disease and blood clotting disorders
 

9:50 Synthetic Vaccine Particles (SVPs) for the prevention of anti-drug antibodies

Kei  Kishimoto

Kei Kishimoto , Chief Scientific Officer, Selecta Biosciences

10:30 Morning Coffee

11:00 Achieving immunological tolerance – are we there yet?

Farnaz Fallah-Arani

Farnaz Fallah-Arani, Group Leader, Pharmacology, UCB

• Can immunological tolerance be achieved clinically?
• Pro’s and Con’s of in vitro and in vivo assays of modelling immunological tolerance pre-clinically will be discussed
• How well do these pre-clinical models translate into the clinic
 

11:40 Evaluation of the immunogenicity of orally administered recombinant human BSSL in a phase III clinical study in pre-term infants

Margareta Wiken

Margareta Wiken, Bioanalytical Manager, Swedish Orphan Biovitrum

• Challenges and limitations due to the vulnerable nature of the pre-term infant population
• Experience gained from preclinical safety studies
• Outcome from the clinical study during a 1 year follow up period
 

12:20 Networking Lunch

13:20 Early immunogenicity assessment of biotherapeutics: a decade at a glance

Sofie Pattijn

Sofie Pattijn, Chief Technology Officer, ImmunXperts

• Prediction versus assessment?
• A time for standardisation and harmonisation
• Managing expectations
• Innovations and developments

14:00 Predicting T cell immunogenicity; Moving beyond MHC binding

Morten Nielsen

Morten Nielsen, Associate Professor, The Technical University Of Denmark

• T cell epitopes must bind one or more of the host's MHC molecules
• For CTL epitope, this binding event is highly predictive for T cell immunogenicity, for T helper responses this is the case only to a limited extend
• Overview of recent advances in tools for prediction of peptide binding to MHC class II molecule and limitations in improving the accuracy of these methods
• Explore features other than MHC binding that might be critical for identification of T cell epitopes
 

 

14:40 Afternoon Tea

15:20 Immune tolerant mice as the model for studying immunogenicity?

Grzegorz Kijanka

Grzegorz Kijanka, Postdoctoral Researcher , Leiden Academic Centre for Drug Research, Leiden University

• Types of immune tolerant mouse models
• What can we learn from immune tolerant mice about the immunogenicity mechanism?
• Can immune tolerant mice be used for immunogenicity prediction?
• Future of immune tolerant mice models
 

16:00 Validation of cell based antibody neutralisation assays

Bassam Hallis

Bassam Hallis, Head of Pre-Clinical Development, Public Health England

• Challenges of development of validation of cell based assays
• Can cell based assays be quantitative?
• Which parameters can be validated?
• System suitability for cell based assays
 

16:40 Mission Impossible? Tweaking Bridging ELISA to Achieve Required Drug Tolerance for ADA Detection of Therapeutic Antibodies

Linglong Zou

Linglong Zou, Director of Experimental Immunology, Teva Pharmaceuticals

• An updated view of drug tolerance requirement for an ADA assay
• Benefit of achieving adequate drug tolerance for immunogenicity testing and data reporting
• Advantage of non-acid dissociation method for drug tolerance improvement
• Case study illustrating how to tweak Bridging ELISA to enhance drug tolerance
 

17:20 Chair’s Closing Remarks and Close of Day One

Guilhem Richard

Guilhem Richard, Computational Immunologist, EpiVax Inc

8:30 Registration & Coffee

9:00 Chair's Opening Remarks

Marsilio  Adriani

Marsilio Adriani, Postdoctoral Research Associate, University College London

9:10 Predicting Immunogenicity in the Era of Personalized Medicine: A Need for Individual Risk Assessment

Guilhem Richard

Guilhem Richard, Computational Immunologist, EpiVax Inc

  • Immunogenicity of biologics is widely acknowledged to be a barrier to clinical success.
  • Means for pre-screening patients and identifying those as risk of developing anti-drug antibodies (ADA) have been lacking.
  • Our proprietary in silico tools can identify pairs of high-, moderate-, and low-risk HLA haplotypes for a given protein.
  • We analyzed data from patients exposed to monoclonal antibody, and observed higher ADA responses in patients with high-risk HLA haplotypes compared to patients with low-risk haplotypes.
     
  • 9:50 RG7787 - The coming of age of immunotoxins for solid tumour therapy. Are we there yet?

    Gerhard Niederfellner

    Gerhard Niederfellner, Head of Tumour Cell Biology, Pharma Research & Early Development , Roche Innovation Center Penzberg

    10:30 Morning Coffee

    11:00 Immunogenicity prediction and assessment of nanobodies

    Chloe Ackaert

    Chloe Ackaert, Postdoctoral Researcher, Cellular and Molecular Immunology, Free University Of Brussels

    • Nanobodies: an emerging, promising class of biotherapeutics
    • Interaction between nanobodies and primary dendritic cells
    • ADA assessment towards nanobodies in Phase I
     

    11:40 Peptide immunotherapy for the treatment of autoimmune disease – closer to a cure?

    Emma Smith

    Emma Smith, Senior Group Leader, UCB

    • Why peptide immunotherapy over conventional treatments?
    • Peptide immunotherapy in preclinical models
    • Translating efficacy from preclinical models into the clinic
     

    12:20 Networking Lunch

    13:20 ABIRISK: using immunological signatures to predict immunogenicity

    Marsilio  Adriani

    Marsilio Adriani, Postdoctoral Research Associate, University College London

    • Aims of ABIRISK immunology program
    • Using a high throughput flow cytometry platform to identify novel predictive markers
    • Progress with MS patients treated with Interferon-beta
     

    14:00 Afternoon Tea

    14:30 The two main outcomes of T cell amplification assays for immunogenicity prediction: T cell repertoire and epitopes

    Bernard Maillere

    Bernard Maillere, Research Director and Head, Immunology Laboratory, Institute of Biology and Technologies

    • Why are T cell assays performed to predict immunogenicity?
    • What kind of data do they produce?
    • Do they have been already confronted to clinical observations?
    • Are they really useful as compared to other predictive approaches?

    15:10 An integrated approach to managing immunogenicity risk and drug immune modulation

    Jeremy Fry

    Jeremy Fry, Assay Specialist , ProImmune Ltd.

    • Learn how data from cell-based assays, physical MHC-peptide binding assays, mass spectrometry antigen presentation assays and whole blood   cytokine storm risk management assays can be integrated to characterize immune responses against, or caused by, biotherapeutic drugs
    • Improve decision-making in lead selection, lead characterisation and re-engineering options
     

    15:50 Designing therapeutic drugs with reduced immunogenicity

    Gary Bembridge

    Gary Bembridge, Business Development Manager, Antitope

  • The importance of T cell help has been widely accepted as a significant risk factor in the development of anti-drug antibodies (immunogenicity).
  • Case study data will be presented on the deimmunisation of naturally immunogenic non-human protein therapeutics.
  • 16:30 Chair's Closing Remarks and Close of Day Two

    Sandra Garces

    Sandra Garces, Rheumatologist Consultant and Researcher , Garcia de Orta’s Hospital

    +

    FEATURED SPEAKERS

    Chloe Ackaert

    Chloe Ackaert

    Postdoctoral Researcher, Cellular and Molecular Immunology, Free University Of Brussels
    David Wraith

    David Wraith

    Chief Scientific Officer and Founder, Apitope International NV
    Gerhard Niederfellner

    Gerhard Niederfellner

    Head of Tumour Cell Biology, Pharma Research & Early Development , Roche Innovation Center Penzberg
    Margareta Wiken

    Margareta Wiken

    Bioanalytical Manager, Swedish Orphan Biovitrum
    Morten Nielsen

    Morten Nielsen

    Associate Professor, The Technical University Of Denmark
    Sandra Garces

    Sandra Garces

    Rheumatologist Consultant and Researcher , Garcia de Orta’s Hospital

    Bassam Hallis

    Head of Pre-Clinical Development, Public Health England
    Bassam Hallis

    Bernard Maillere

    Research Director and Head, Immunology Laboratory, Institute of Biology and Technologies
    Bernard Maillere

    Chloe Ackaert

    Postdoctoral Researcher, Cellular and Molecular Immunology, Free University Of Brussels
    Chloe Ackaert

    David Wraith

    Chief Scientific Officer and Founder, Apitope International NV
    David Wraith

    Emma Smith

    Senior Group Leader, UCB
    Emma Smith

    Farnaz Fallah-Arani

    Group Leader, Pharmacology, UCB
    Farnaz Fallah-Arani

    Gary Bembridge

    Business Development Manager, Antitope
    Gary Bembridge

    Gerhard Niederfellner

    Head of Tumour Cell Biology, Pharma Research & Early Development , Roche Innovation Center Penzberg
    Gerhard Niederfellner

    Grzegorz Kijanka

    Postdoctoral Researcher , Leiden Academic Centre for Drug Research, Leiden University
    Grzegorz Kijanka

    Guilhem Richard

    Computational Immunologist, EpiVax Inc
    Guilhem Richard

    Jeremy Fry

    Assay Specialist , ProImmune Ltd.
    Jeremy Fry

    Kei Kishimoto

    Chief Scientific Officer, Selecta Biosciences
    Kei  Kishimoto

    Linglong Zou

    Director of Experimental Immunology, Teva Pharmaceuticals
    Linglong Zou

    Margareta Wiken

    Bioanalytical Manager, Swedish Orphan Biovitrum
    Margareta Wiken

    Marsilio Adriani

    Postdoctoral Research Associate, University College London
    Marsilio  Adriani

    Morten Nielsen

    Associate Professor, The Technical University Of Denmark
    Morten Nielsen

    Sandra Garces

    Rheumatologist Consultant and Researcher , Garcia de Orta’s Hospital
    Sandra Garces

    Shivanthy Visvalingam

    Manager EU Regulatory Strategy for Biosimilars, Pfizer
    Shivanthy  Visvalingam

    Sofie Pattijn

    Chief Technology Officer, ImmunXperts
    Sofie Pattijn

    Sponsors and Exhibitors

    Official Media Partner

    Supporters

    Is your name on the list for Immunogenicity 2015?

    Download

    Sponsors and Exhibitors


    Antitope

    Sponsors and Exhibitors
    http://www.antitope.com/

    Antitope is a leading provider of solutions to enable the development of better biopharmaceuticals. Our mission is to apply these technologies as a comprehensive service for the preclinical prediction of immunogenicity, and for the generation of non-immunogenic fully humanized antibodies, non-immunogenic therapeutic proteins and high yielding manufacturing cell lines. To date, we have entered into multiple agreements with pharmaceutical and biotechnology companies worldwide to apply our technologies for the development of improved biologics. Following its recent merger with PolyTherics Ltd., we now provide an extensive suite of technologies for development of more homogeneous and stable antibody drug conjugates (ADCs) through ThioBridge™, site-specific PEGylation and low viscosity polymers.


    SQI Diagnostics, Inc.

    Sponsors and Exhibitors
    http://www.sqidiagnostics.com

    SQI Diagnostics is a life sciences company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics. SQI has automated, miniaturized, and multiplexed immunogenicity and bioanalytics testing using patented technology making it the only company in the world capable of ADA, epitope mapping, multiplexed PK assays, and many other assays all in one well. The Company’s proprietary microarray tests and fully-automated systems are designed to simplify workflow, increase throughput, reduce costs and provide excellent data quality. With products in both the IVD and pharmaceutical space, SQI is able to serve both marketplaces with the unparalleled level of quality researchers and clinical laboratorians have come to expect.

    Media Partners


    The Protein Society

    Official Media Partner
    http://www.proteinsociety.org

    The Protein Society is an international, trans-disciplinary community of investigators dedicated to the study of protein structure, function, and design. A non-profit scientific and educational organization, the Society provides forums for scientific collaboration and communication with respect to all aspects of protein science.

    Media Partners


    Biosave

    Supporters
    http://www.Biosave.com

    Biosave.com brings together the best Life Science promotions, product releases, featured products, publications, videos and events from 100’s of leading Life Science suppliers. Updated 24 hours a day, Biosave is constantly uploading special promotions and exciting product news that you won’t find anywhere else. Our goal is to provide our users with the most exclusive product information to help reach that all important purchasing decision.


    Cutting Edge

    Supporters
    http://www.cuttingedgeinfo.com

    Cutting Edge Information provides customized research and benchmarking reports to pharmaceutical, biotechnology and other life science companies. We provide off-the-shelf and customized research for key areas including medical affairs, clinical development, market access, regulatory affairs, marketing management, sales and HCP fair market value.


    International Journal of Medical Engineering and Informatics

    Supporters
    http://www.inderscience.com/ijmei

    IJMEI promotes an understanding of the structural/functional aspects of disease mechanisms and the application of technology towards the treatment/management of such diseases. It seeks to promote interdisciplinary collaboration between those interested in the theoretical and clinical aspects of medicine and to foster the application of computers and mathematics to problems arising from medical sciences. IJMEI includes authoritative review papers, the reporting of original research, and evaluation reports of new/existing techniques and devices. Each issue also contains a comprehensive information service.


    Human Immunology News

    Supporters
    http://www.humanimmunologynews.com/hin?utm_source=Immunogen2015&utm_medium=logo&utm_campaign=hinImmunogen2015

    Human Immunology News is a free, weekly e-newsletter that keeps members of the human immunology community informed by providing the latest news from all areas of the field, including science, research and business, to regulatory affairs. Subscribe now to stay current in the latest research news.


    PharmCast

    Supporters
    http://www.PharmCast.com

    www.PharmCast.com is the world leading website designed specifically for pharmaceutical, clinical and biotechnology professionals. www.PharmCast.com brings up-to-date information on pharmaceutical patents, FDA, news, jobs and Buyer's Guide to our visitors. It was created and is maintained by pharmaceutical and biotechnology professionals. Visit www.PharmCast.com and discover for yourself why it is so popular among professionals.


    Contract Biotechnology

    Supporters
    http://www.contract-biotechnology.com

    Contract-Biotechnology.com is a web-based platform for laboratory outsourcing solutions. We are an online R&D matching tool that connects Scientifics and organizations involved in discovery, development and delivery of new healthcare products with service and products providers worldwide. Life science information technology is undergoing a revolution. Part of that revolution involves new, unexplored business models, open innovation, open data and collaboration. If you have a project or idea that you would like to propose, develop or run, we can help. A New Collaboration Network Model for Discovery Research and Development • Effective Platform: the 95% • 5.000 registered users // > 15.000 Newsletter subscribers • Geographical background: 45,5% Europe / 37,5% North America / 16,5% Asia / 0,5% ROW • Professional background: Outsourcing Manager, Project Manager, CEO, Business Developer, CSO, Account Manager, Sales & Marketing People, Scientists, R&D. For further information, please visit our website www.contract-biotechnology.com


    PharmaVOICE

    Supporters
    http://www.pharmavoice.com

    PharmaVOICE magazine, and its supporting VIEW publications, provide commentary about the challenges and trends impacting the life-sciences industry, covering a range of issues from molecule through market. PharmaVOICE's more than 41,000 U.S.-based subscribers are also kept abreast of the latest trends through additional media resources, including WebSeminars, Podcasts, Videocasts, and White Papers.


    International Journal of Biotechnology

    Supporters
    http://www.inderscience.com/ijbt

    IJBT provides an international forum and refereed authoritative source of information in the field of Biotechnology and Biotechnics, with emphasis on management and economics, as well as the political and social issues. It aims to disseminate knowledge, provide a learned reference in the field, and establish channels of communication between academic and research experts, policy makers and executives in industry, commerce and investment institutions.


    PMR

    Supporters
    http://www.pmrcorporate.com

    PMR (www.pmrcorporate.com) is a British-American company providing market information, advice and services to international businesses interested in Central and Eastern European countries as well as other emerging markets. PMR's key areas of operation include business publications (through PMR Publications), consultancy (through PMR Consulting) and market research (through PMR Research ). Being present on the market since 1995, offering high international standards in projects and publications, as well as providing one of the most frequently visited and top-ranked websites, PMR is one of the largest companies of its type in the region.


    Lab Bulletin

    Supporters
    http://www.labbulletin.com

    Lab Bulletin is a free online resource for scientists and laboratory professionals where you can catch up on the latest news for laboratory products and services. You will find an extensive directory of laboratory suppliers and manufacturers enabling you to contact companies quickly and easily to request further information. Lab Bulletin also publishes four free monthly E-Newsletters keeping you up-to-date with all of the latest laboratory products and industry news directly to your inbox. We have dedicated E-Newsletters for Chromatography and Spectroscopy, Microscopy and Image Analysis, weekly Industry News updates and our monthly Lab Bulletin E-Newsletter sent out to over 29,000 readers worldwide. To request your free copy click here


    Medical News Today

    Supporters
    http://www.medicalnewstoday.com

    Medical News Today is the largest independent medical and health news site on the web - with over 10,000,000 monthly unique users it is ranked number one for medical news on all major search engines. Medical News Today is used by pharmaceutical, biotech and health organizations, advertising agencies, PR companies and vertical ad networks to deliver targeted campaigns to HCPs, patients and caregivers. To find out how Medical News Today can help you to reach the right audience contact peter@medicalnewstoday.com or visit www.medicalnewstoday.com.


    pharmaphorum

    Supporters
    http://www.pharmaphorum.com

    pharmaphorum drives innovation within the pharmaceutical industry, by bringing healthcare together through a suite of media services that help produce and disseminate thought leadership, combined with an online platform for communicating messages to a global audience.Visit www.pharmaphorum.com


    Labhoo

    Supporters
    http://www.labhoo.com



    Technology Networks

    Supporters
    http://www.technologynetworks.com

    Founded in 2000, Technology Networks is established as the leading news provider for life science and drug discovery professionals. In addition, we provide unique content including webcasts, videos, application notes and posters from recent conferences. Our portfolio now includes around 30 focussed scientific communities, all of which are accessible free of charge within TechnologyNetworks.com


    Farmavita

    Supporters
    http://www.farmavita.net/

    Farmavita Net is professional community and network of pharmaceutical licensing and business development executives, innovators and researchers
    Farmavita.Net is the pharmaceutical licensing, technology transfer and regulatory affairs network. We are managing the marketplace of offers and demand for pharmaceutical Dossiers, know-how and technologies. Members of Farmavita.Net network usually find a number of attractive solutions for business development, alliances, joint ventures, co-development and co-marketing of pharmaceutical products. Farmavita.Net is not just a pure Internet portal. We manage a number of regional associates. We are connecting the dynamic network of few hundreds members / pharmaceutical companies interested in license-in and license-out opportunities.


    Immune Regulation News

    Supporters
    http://www.immuneregulationnews.com/irn?utm_source=Immunogen2015&utm_medium=logo&utm_campaign=irnImmunogen2015

    Immune Regulation News is a free, weekly e-newsletter that keeps members of the immune regulation community informed by providing the latest news from all areas of the field, including science, research and business, to regulatory affairs. Subscribe now to stay current in the latest research news.


    Labsave

    Supporters
    http://www.labsave.com

    Labsave is the leading savings website for Laboratory Equipment and Lab Supplies. We work closely with the top suppliers in the world to bring you the best products at the most competitive prices. We are constantly striving to secure the biggest and most exclusive offers that you won’t find anywhere else! http://www.labsave.com/


    GBI

    Supporters
    http://www.gbihealth.com/

    GBI is an information, applications, and services company focused on the healthcare industry. Leveraging data from across the healthcare value chain, GBI creates web and mobile applications that enable individuals and organizations to make better decisions and communicate more effectively.


    International Journal of Bioinformatics Research and Applications

    Supporters
    http://www.inderscience.com/ijbra

    Bioinformatics is an interdisciplinary research field that combines biology, computer science, mathematics and statistics into a broad-based field that will have profound impacts on all fields of biology. The emphasis of IJBRA is on basic bioinformatics research methods, tool development, performance evaluation and their applications in biology. IJBRA addresses the most innovative developments, research issues and solutions in bioinformatics and computational biology and their applications.


    Drug Development Technology

    Supporters
    http://www.drugdevelopment-technology.com

    Drugdevelopment-technology.com covers every aspect of the drug development and research process, from conception to pre-FDA approval. Our global network of journalists updates the site with the latest and most significant industry developments. This coverage allows us to provide everyone - from senior management through to research and QA staff – with in-depth reviews of the latest projects, advance notice of new product releases and analysis of the latest procedural and legislative developments.


    Int. J. of Immunological Studies

    Supporters
    http://www.inderscience.com/ijis

    IJIS publishes a broad range of papers on all aspects of immunology from scientists in academic and non-academic organisations as well as business and government worldwide. IJIS is the flagship journal of the Frontiers in Immunology Research Network.


    International Pharmaceutical Industry

    Supporters
    http://www.ipimediaworld.com

    IPI gives you an insight into all areas of Biopharm, Medical, Pharmaceutical and Healthcare. IPI provides a proven supportive means of communication to the Pharmaceutical, Bio Pharmaceutical, Nutraceutical and Medical Devices industry, incorporating the latest in research and technology innovations, regulatory guidelines, marketing and communication strategies.


    Pharmiweb

    Supporters
    http://www.pharmiweb.com

    Established in October 2003, PharmiWeb Solutions is an energetic, innovative provider of web-based solutions for the pharmaceutical sector, with customers such as AstraZeneca, Roche, Servier Laboratories, and Merck With solutions in three key areas: Online Publishing, e-Business and Mobile Computing, we deliver connectivity – between people and applications – unlocking islands of data and knowledge. We own some of the sector’s most innovative Online Publications: PharmiWeb.com, HospitalPharma.com and Detail-Direct.com. We are actively developing solutions for Mobile Computing platforms. For example, our PharmiTabTM e-pharmacy solution runs real-time patient data and prescribing transactions in a busy hospital environment, on a TabletPC, wireless client/server platform. e-Business solutions range from e-Detailing, to Online Market Research, all designed to increase reach, increase sales, and to reduce administration and costs.


    International Journal of Computational Biology and Drug Design

    Supporters
    http://www.inderscience.com/ijcbdd

    IJCBDD, an International Society of Intelligent Biological Medicine official journal, bridges the gap between two very important, complementary disciplines, computational biology and drug design. Through advances in high-throughput genome sequencing and digital imaging technologies, biocomputing, drug design and medical research have unfolded new, predictive sciences such as genomics, proteomics, lipidomics, metabolomics, cytomics and pharmaconomics. These promote new computational, statistical and biomedical approaches to drug design/development, besides unleashing the potential of significantly more accurate, effective personalised diagnosis, therapeutics and patient care.


    Select Science

    Supporters
    http://www.selectscience.net/

    SelectScience is an independent, online information resource for the worldwide scientific community, and the home of trusted information for laboratory scientists. Discover impartial, expert opinion and trusted reviews about latest laboratory equipment and techniques; plus videos, application notes and science news from around the world. Become a member for free today.


    Drug Target Review

    Supporters
    http://www.drugtargetreview.com

    Drug Target Review’s quarterly magazine, website and annual events program provides high quality content with peer-written articles that are submitted exclusively by the world’s most respected scientists in their field. This attracts a committed base of readers, users and delegates made up of senior decision-makers from the life science and drug discovery industries at the top pharmaceutical companies, as well as academics and scientists from the top research institutes across the globe.


    CanBiotech

    Supporters
    http://www.canbiotech.com

    CanBiotech - A Portal and B2B Outsourcing Marketplace for the Biotech and Pharmaceutical Industry. The Marketplace features the Outsourcing Services Showcase; the Portal features our biopharmaceutical and venture capital directories and databases. Publications include the BioMedical Outsourcing Report and the Bio Outsourcing Asia© Publication.


    Pharmalicensing

    Supporters
    http://www.pharmalicensing.com

    Pharmalicensing (www.pharmalicensing.com) is the premier biopharmaceutical Open Innovation resource designed for professionals involved with partnering, licensing and business development worldwide. Actively supporting all forms of partnering and in- and out-licensing activities, Pharmalicensing utilizes the unique Partnering Search service and its global network of industry experts to enable companies to identify and engage with appropriate partners around the world. Pharmalicensing, and its sister service Medical Device Licensing (www.medicaldevicelicensingcom) are actively utilized by over 200,000 industry professionals each month. Pharmalicensing is a division of IP Technology Exchange, Inc.


    Absave

    Supporters
    http://www.absave.com

    Absave.com is the leading savings website for Antibodies and Immunological Products. Search our extensive database of Antibodies, Kits, Proteins & Peptides, Reagents, etc. to find the best savings!


    Drug Discovery Today

    Supporters
    http://www.drugdiscoverytoday.com/

    Drug Discovery Today is one of the most cited review journals in the field of drug discovery, with an impact factor of 6.422.
    Drug Discovery Today will benefit your research by helping to keep you up-to-date with all of the fast-moving and emerging topics in drug discovery. Each issue is packed full of the latest research news, peer-reviewed articles and comment and opinion from leading research scientists.


    Immunology of Infectious Disease News

    Supporters
    http://www.immunologyofinfectiousdiseasenews.com/iidn?utm_source=Immunogen2015&utm_medium=logo&utm_campaign=iidnImmunogen2015

    Immunology of Infectious Disease News is a free, weekly e-newsletter that keeps members of the infectious disease community informed by providing the latest news from all areas of the field, including science, research and business, to regulatory affairs. Subscribe now to stay current in the latest research news.


    LabRoots

    Supporters
    http://www.labroots.com/

    LabRoots is a free, social networking site that enables scientists, engineers, and other technical professionals to connect, collaborate with, and learn from each other. LabRoots fosters world-wide scientific communication and incorporates the newest social networking technologies. LabRoots allows scientists to connect with each other as they describe their research interests on a myriad of unique features and tools, discovering meaningful collaborations across geographic boundaries and fields of expertise.


    Bioportfolio Limited

    Supporters
    http://www.bioportfolio.com

    BioPortfolio.com is a leading news, information and knowledge resource covering the global life science industries impacted by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to source core information on specific bio-related topics, to collate relevant data associated with each topic and to point the user to relevant knowledge resources


    Pharmavision

    Supporters
    http://www.pharmavision.co.uk

    PharmaVision offers a consultancy service providing independent pharmaceutical thematic research to the healthcare industry, the investment community and competitive intelligence specialists. We perform due diligence research and provide expert commentary in healthcare. Our reports combine scientific analysis in drug delivery, R&D technologies and pharmaceutical products including patient modelling, product/technology forecasts and market trends evaluation.


    Pharmaceutical Technology

    Supporters
    http://www.pharmaceutical-technology.com

    Pharmaceutical-technology.com is the only website focusing specifically on issues relevant to pharmaceutical professionals working with technology, be it development, engineering, IT or production. Pharmaceutical-technology.com brings you the latest in industry projects and updates, along with the news, views and trends that leading professionals – from senior executives to manufacturing managers and heads of procurement – require to stay on top of their field.


    http://www.fiercebiotech.com" target="_blank"> sponsor image

    FierceBiotech

    Supporters
    http://www.fiercebiotech.com" target="_blank" class="link" align="right"> http://www.fiercebiotech.com

    FierceBiotech is the biotech industry's daily monitor. Biotech executives rely on FierceBiotech to stay up to speed on biotech corporations, FDA approvals & regulations, industry mergers & acquisitions, clinical trials, and more. Beyond the news of the day, our editors produce in-depth features on industry leaders and up-and-comers, the regulatory environment, and market trends. In addition to our comprehensive website and free email newsletter, you have the opportunity to attend our webinars, peruse our whitepaper library and benefit from our eBooks. Advance your career through our exclusive networking parties and life sciences job board.


    Gate2Biotech

    Supporters
    http://www.gate2biotech.com

    Gate2Biotech is a portal that unites biotechnological community in Central Europe. It covers all the news in the field of biotechnology. Thanks to the the portal the companies engaged in the field can easily search for research institutions and other partners to solve technical problems they are facing and here they can also present their services offer to potential partners from the Czech Republic and abroad. Gate2Biotech portal serves as a bridge connecting scientific and commercial sector. It incorporates offices and support organizations dedicated to promoting transfer of innovative technologies into a unified communication platform of Czech and international biotechnologies. As a mediator of information it draws attention to biotechnologies and support of their application and transfer into practice. It also functions as a tool for encouraging non-professionals (especially scientists and students) towards innovative business or applied research.

    Marriott Hotel Regents Park

    128 King Henry’s Road
    London NW3 3ST
    United Kingdom

    Marriott Hotel Regents Park

    This 4 star north London hotel in zone 2 is the perfect destination for the astute business traveler as well as the leisure guest that knows how convenient north London hotels are, as a base from which to explore the city .Bond Street is just 3 stops from Swiss Cottage underground station on the Jubilee Line, so you can be shopping, exploring the sights and taking in one of London’s world-renowned West End shows in less than 15 minutes when you stay at this hotel near central London. At the same time, the hive of activity that is Camden Town, the chic shops, cafes and restaurants of Primrose Hill and ZSL’s London Zoo in Regents Park are all just a short walk from this hotel in north London.

    HOTEL BOOKING FORM

    Title

    SubTitle
    speaker image

    Content


    Title


    Description

    Download


    WHAT IS CPD?

    CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

    ‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

    CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

    Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

    CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.

    CPD AND PROFESSIONAL INSTITUTES

    There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

    For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

    CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.

    TYPICAL CPD SCHEMES AND RECORDING OF CPD (CPD points and hours)

    Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

    ‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

    ‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

    The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

    As a formal provider of CPD certified activities, SMI Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.

    GLOBAL CPD

    Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

    CPD Certificates

    We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@smi-online.co.uk

    Event Title

    Headline

    Text
    Read More

    I would like to speak at an event

    I would like to attend an event

    I would like to sponsor/exhibit at an event

    SIGN UP OR LOGIN

    Sign up
    Forgotten Password?

    Contact SMi GROUP LTD

    UK Office
    Opening Hours: 9.00 - 17.30 (local time)
    SMi Group Ltd, 1 Westminster Bridge Road, London, SE1 7XW, United Kingdom
    Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
    Website: http://www.smi-online.co.uk Email: events@smi-online.co.uk
    Registered in England No: 3779287 VAT No: GB 976 2951 71




    Forgotten Password

    Please enter the email address you registered with. We will email you a new password.